Sign inJoin waitlistJoin the waitlist

Sreenivasa Chandana

Physician · Cancer and Hematology Centers of Western Mi, P.c.

Credentials: · · · · ·

History

Cancer and Hematology Centers of Western Mi, P.c.
Present

Hematology and Medical Oncology
Michigan State University
1999–2002
Internal Medicine
McLaren-Flint
1996–1999
GUNTUR MED COLL, UNIV OF HLTH SCI, GUNTUR, ANDHRA PRADESH, INDIA
1992–1996

Research

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
Journal of Clinical Oncology · 2019 · 529 citations
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
The Lancet · 2023 · 424 citations
Pancreatic Cancer: A Review of Current Treatment and Novel Therapies
Review · Journal of Investigative Surgery · 2023 · 319 citations

Hani Babiker
9 papers
Daruka Mahadevan
7 papers
Barbara Conley
6 papers
Anup Kasi
4 papers
Gerald Wright
4 papers
Hordur Kolbeinsson
4 papers
Mathew Chung
4 papers
Tanios Bekaii-Saab
4 papers
AJ
Adham Jurdi
3 papers
Akshay Amaraneni
3 papers · 3 as a resident
Alejandro Boiles
3 papers · 2 as a fellow
AP
Andrew Paulson
3 papers

Clinical trials

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Site PI · Recruiting · Phase 2
Verastem, Inc.
2026–2028
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Site PI · Recruiting · Phase 2
Verastem, Inc.
2026–2028
A Study of ZW251 in Participants With Advanced Solid Tumors
Site PI · Recruiting · Phase 1
Zymeworks BC Inc.
2025–2028
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Site PI · Recruiting · Phase 1, Phase 2
Tasca Therapeutics
2025–2029